Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Vortioxetine Hydrobromide Tablets

Approval Number

国药准字H20243891

Company山东京卫制药有限公司

Registration Date

June 4, 2024

Drug Information

Generic Name

氢溴酸伏硫西汀片

Dosage Form

片剂

Strength

10mg（以C₁₈H₂₂N₂S计）

Drug Type

化学药品

Registration Date

June 4, 2024

Company Information

Applicant Company

Company Name山东京卫制药有限公司

Company Address

山东省泰安市高新技术产业开发区配天门大街西首

Manufacturing Company

Company Name山东京卫制药有限公司

Company Address

山东省泰安高新技术产业开发区配天门大街西首

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy